findmyKOL
Clinical trialNCT00490620CompletedPhase 2/PHASE3Interventional

Study of Combivir for Patients With Primary Biliary Cirrhosis

SponsorUniversity of AlbertaEnrollment59Primary Biliary Cirrhosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Alberta

    Edmonton, Alberta, Canada

  • University of Montreal

    Montreal, Quebec, Canada

United Kingdom
  • University of Birmingham

    Birmingham, England, United Kingdom

United States
  • Mayo Clinic

    Rochester, Minnesota, United States

  • St Louis University

    St Louis, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2004
Primary completion
—
Completion
30 Apr 2007
Last update posted
1 Nov 2007
Registered enrollment
59
Registry id
NCT00490620
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.